These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8998543)

  • 1. [Aseptic meningitis during treatment with immunoglobulins].
    Sirvent N; Monpoux F; Benet L; Mariani R
    Arch Pediatr; 1996 Aug; 3(8):830-1. PubMed ID: 8998543
    [No Abstract]   [Full Text] [Related]  

  • 2. Aseptic meningitis and intravenous gammaglobulin treatment.
    Ozsoylu S
    Am J Dis Child; 1993 Feb; 147(2):129-30. PubMed ID: 8489588
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous immunoglobulins and aseptic meningitis].
    Mselati JC; Carlier JC; Routon MC; Noui Mehidi F; de Gennes C
    Arch Fr Pediatr; 1992 Mar; 49(3):216. PubMed ID: 1610283
    [No Abstract]   [Full Text] [Related]  

  • 4. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?
    Preminger-Shapiro R; Nussinovitch M; Soen G; Varsano I
    Eur J Pediatr; 1995 Oct; 154(10):866-7. PubMed ID: 8529693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease].
    García Norniella B; Morán Poladura M; Fernández Díaz M; Fernández Fernández E; Suárez Castañón C
    An Pediatr (Barc); 2011 Jul; 75(1):79-80. PubMed ID: 21420919
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute aseptic meningitis associated with administration of intravenous immune globulin.
    Pallares DE; Marshall GS
    Am J Pediatr Hematol Oncol; 1992 Aug; 14(3):279. PubMed ID: 1510200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aseptic meningitis following treatment with immunoglobulins: physiopathological and prognostic value of screening].
    Oddou S; Molinier S; Coso D; Boulet JM; Gastaut JA; Bouabdallah R
    Presse Med; 1995 May; 24(19):916. PubMed ID: 7638138
    [No Abstract]   [Full Text] [Related]  

  • 8. Human intravenous immunoglobulin-induced aseptic meningitis: a case report.
    Chaabane A; Hamzaoui A; Aouam K; Klai R; Fredj NB; Boughattas NA; Mahjoub S
    J Clin Pharmacol; 2012 Feb; 52(2):279-81. PubMed ID: 21257801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis].
    Puy-Nunez A; Dacosta-Balboa M; Cabo-Lopez I; Canneti B; Lopez-Ferreiro A; Rodriguez-Alvarez JR; Rodriguez-Regal A; Mourino-Sestelo MA
    Rev Neurol; 2016 May; 62(10):478-9. PubMed ID: 27149191
    [No Abstract]   [Full Text] [Related]  

  • 10. Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid.
    Obando I; Duran I; Martin-Rosa L; Cano JM; Garcia-Martin FJ
    Pediatr Emerg Care; 2002 Dec; 18(6):429-32. PubMed ID: 12488836
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome.
    Maldonado Slootjes S; Guilmot A; Dubuisson N; van Pesch V; Elsankari S
    Acta Neurol Belg; 2020 Aug; 120(4):1015-1016. PubMed ID: 32449133
    [No Abstract]   [Full Text] [Related]  

  • 13. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
    Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
    Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased levels of Monocyte Chemoattractant Protein-1 in cerebrospinal fluid with gamma globulin induced meningitis.
    Asano T; Koizumi S; Mishina-Ikegami K; Hatori T; Miyasho T; Fujino O
    Acta Paediatr; 2010 Feb; 99(2):164-5. PubMed ID: 19832741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C; Guy N; Besson G
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Idiopathic thrombopenic purpura, intravenous immunoglobulins and aseptic meningitis].
    Piguet C; Fontmarty S; Gilbert B; Vodoff MV; de Lumley L
    Arch Pediatr; 1999 Dec; 6(12):1350-1. PubMed ID: 10627912
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced aseptic meningitis.
    Hopkins S; Jolles S
    Expert Opin Drug Saf; 2005 Mar; 4(2):285-97. PubMed ID: 15794720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced aseptic meningitis.
    Nettis E; Calogiuri G; Colanardi MC; Ferrannini A; Tursi A
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Jun; 3(2):143-9. PubMed ID: 12769786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aseptic meningitis induced by intravenous immunoglobulins in a child with acute Epstein-Barr virus infection and thrombocytopenia.
    Vassalini P; Ajassa C; Di Ruscio V; Morace A; Vergari J; Tosato C; Savelloni G; Mastroianni CM
    Infez Med; 2019 Jun; 27(2):194-197. PubMed ID: 31205046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aseptic meningitis during treatment with very low doses of intravenous immunoglobulins].
    Attout H; Mallet H; Desmurs H; Berthier S; Gil H; de Wazières B; Dupond JL
    Rev Med Interne; 1998 Feb; 19(2):140-1. PubMed ID: 9775133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.